top of page
Targeted Solutions for Weight Management and Metabolic Health
Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
April 23, 2024
Response Pharmaceuticals Announces Successful Completion of Phase 1B Clinical Trial for RDX-002
August 17, 2023
bottom of page